Vivos Inc Obtains Feedback from the FDA on Clinical Testing of RadioGel™
02 déc. 2021 09h30 HE
|
Vivos Inc.
Richland WA, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), on November 30 Vivos Inc met with the Food and Drug Administration to obtain suggestions on improving the current draft of...